Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 5720-5732

  Basu, Sreemanti ^a,b   Ray, Avijit ^a   Dittel, Bonnie N ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; B LYMPHOCYTE RECEPTOR; CANNABINOID 2 RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G2C; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; NOTCH2 RECEPTOR; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANNABINOID 2 RECEPTOR GENE; CELL LINEAGE; CHIMERA; CONTROLLED STUDY; GENE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INTRACELLULAR SIGNALING; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MARGINAL ZONE B CELL; MOUSE; NONHUMAN; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; CELL LINEAGE; CELL MOVEMENT; CELL SEPARATION; CHEMOTAXIS, LEUKOCYTE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, CANNABINOID, CB2; SPLEEN;

EID: 82755192209     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102195     Document Type: Article

References (67)

1. Basu, S., and B. N. Dittel. 2011. Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulaton in health and disease. Immunol. Res. 51: 26-38.
2. Mechoulam, R., S. Ben-Shabat, L. Hanus, M. Ligumsky, N. E. Kaminski, A. R. Schatz, A. Gopher, S. Almog, B. R. Martin, D. R. Compton, et al. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50: 83-90.
3. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949. (Pubitemid 23026736)
4. Munro, S., K. L. Thomas, and M. Abu-Shaar. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65. (Pubitemid 23305569)
5. Matsuda, L. A., S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
6. Galiègue, S., S. Mary, J. Marchand, D. Dussossoy, D. Carrière, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, and P. Casellas. 1995. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232: 54-61.
7. Van Sickle, M. D., M. Duncan, P. J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J. S. Davison, et al. 2005. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310: 329-332. (Pubitemid 41457202)
8. Sugiura, T., S. Kondo, S. Kishimoto, T. Miyashita, S. Nakane, T. Kodaka, Y. Suhara, H. Takayama, and K.Waku. 2000. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275: 605-612. (Pubitemid 30039024)
9. Pereira, J. P., J. An, Y. Xu, Y. Huang, and J. G. Cyster. 2009. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat. Immunol. 10: 403-411.
10. Sugiura, T., and K. Waku. 2002. Cannabinoid receptors and their endogenous ligands. J. Biochem. 132: 7-12. (Pubitemid 34832264)
11. Bouaboula, M., M. Rinaldi, P. Carayon, C. Carillon, B. Delpech, D. Shire, G. Le Fur, and P. Casellas. 1993. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214: 173-180. (Pubitemid 23168532)
12. Rinaldi-Carmona, M., F. Barth, J. Millan, J. M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, et al. 1998. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284: 644-650. (Pubitemid 28086654)
13. Bouaboula, M., N. Desnoyer, P. Carayon, T. Combes, and P. Casellas. 1999. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol. Pharmacol. 55: 473-480. (Pubitemid 29128103)
14. Tanikawa, T., K. Kurohane, and Y. Imai. 2007. Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice. Microbiol. Immunol. 51: 1013-1019. (Pubitemid 47628647)
15. Ziring, D., B. Wei, P. Velazquez, M. Schrage, N. E. Buckley, and J. Braun. 2006. Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics 58: 714-725. (Pubitemid 44343145)
16. Maresz, K., G. Pryce, E. D. Ponomarev, G. Marsicano, J. L. Croxford, L. P. Shriver, C. Ledent, X. Cheng, E. J. Carrier, M. K. Mann, et al. 2007. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med. 13: 492-497. (Pubitemid 46559830)
17. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196. (Pubitemid 40563168)
18. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335. (Pubitemid 37328755)
19. Treml, L. S., G. Carlesso, K. L. Hoek, J. E. Stadanlick, T. Kambayashi, R. J. Bram, M. P. Cancro, and W. N. Khan. 2007. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J. Immunol. 178: 7531-7539. (Pubitemid 46898021)
20. Oliver, A. M., F. Martin, G. L. Gartland, R. H. Carter, and J. F. Kearney. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27: 2366-2374. (Pubitemid 27404323)
21. Guinamard, R., M. Okigaki, J. Schlessinger, and J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1: 31-36.
22. Fagarasan, S., and T. Honjo. 2000. T-Independent immune response: new aspects of B cell biology. Science 290: 89-92.
23. Girkontaite, I., K. Missy, V. Sakk, A. Harenberg, K. Tedford, T. Pötzel, K. Pfeffer, and K. D. Fischer. 2001. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol. 2: 855-862.
24. Beer, S., T. Scheikl, B. Reis, N. Hüser, K. Pfeffer, and B. Holzmann. 2005. Impaired immune responses and prolonged allograft survival in Sly1 mutant mice. Mol. Cell. Biol. 25: 9646-9660. (Pubitemid 41507862)
25. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190: 75-89. (Pubitemid 29330125)
26. Srivastava, B., W. J. Quinn, III, K. Hazard, J. Erikson, and D. Allman. 2005. Characterization of marginal zone B cell precursors. J. Exp. Med. 202: 1225-1234. (Pubitemid 41586953)
27. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14: 603-615. (Pubitemid 32520871)
28. Kraus, M., L. I. Pao, A. Reichlin, Y. Hu, B. Canono, J. C. Cambier, M. C. Nussenzweig, and K. Rajewsky. 2001. Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail. J. Exp. Med. 194: 455-469. (Pubitemid 32835041)
29. Samardzic, T., J. Gerlach, K. Muller, D. Marinkovic, J. Hess, L. Nitschke, and T. Wirth. 2002. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice. Eur. J. Immunol. 32: 2481-2489.
30. Sun, T., M. R. Clark, and U. Storb. 2002. A point mutation in the constant region of Ig lambda1 prevents normal B cell development due to defective BCR signaling. Immunity 16: 245-255. (Pubitemid 34211964)
31. Shimizu, K., S. Chiba, N. Hosoya, K. Kumano, T. Saito, M. Kurokawa, Y. Kanda, Y. Hamada, and H. Hirai. 2000. Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces cleavage, nuclear translocation, and hyperphosphorylation of Notch2. Mol. Cell. Biol. 20: 6913-6922.
32. Lubman, O. Y., S. V. Korolev, and R. Kopan. 2004. Anchoring notch genetics and biochemistry; structural analysis of the ankyrin domain sheds light on existing data. Mol. Cell 13: 619-626. (Pubitemid 38368120)
33. Artavanis-Tsakonas, S., M. D. Rand, and R. J. Lake. 1999. Notch signaling: cell fate control and signal integration in development. Science 284: 770-776. (Pubitemid 29291335)
34. Mumm, J. S., and R. Kopan. 2000. Notch signaling: from the outside in. Dev. Biol. 228: 151-165. (Pubitemid 32011983)
35. Hozumi, K., N. Negishi, D. Suzuki, N. Abe, Y. Sotomaru, N. Tamaoki, C.Mailhos, D. Ish-Horowicz, S. Habu, and M. J. Owen. 2004. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat. Immunol. 5: 638-644. (Pubitemid 38811889)
36. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18: 675-685. (Pubitemid 36588584)
37. Dalwadi, H., B. Wei, M. Schrage, K. Spicher, T. T. Su, L. Birnbaumer, D. J. Rawlings, and J. Braun. 2003. B cell developmental requirement for the G alpha i2 gene. J. Immunol. 170: 1707-1715. (Pubitemid 36197385)
38. Cinamon, G., M. Matloubian, M. J. Lesneski, Y. Xu, C. Low, T. Lu, R. L. Proia, and J. G. Cyster. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5: 713-720. (Pubitemid 39023303)
39. Tan, J. B., K. Xu, K. Cretegny, I. Visan, J. S. Yuan, S. E. Egan, and C. J. Guidos. 2009. Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches. Immunity 30: 254-263.
40. Buckley, N. E., K. L. McCoy, E. Mezey, T. Bonner, A. Zimmer, C. C. Felder, M. Glass, and A. Zimmer. 2000. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. 396: 141-149. (Pubitemid 30265571)
41. Ray, A., and B. N. Dittel. 2010. Isolation of mouse peritoneal cavity cells. J. Vis. Exp. (35): pii: 1488.
42. Dittel, B. N. 2010. Depletion of specific cell populations by complement depletion. J. Vis. Exp. (36): pii: 1487.
43. Maresz, K., E. J. Carrier, E. D. Ponomarev, C. J. Hillard, and B. N. Dittel. 2005. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 95: 437-445. (Pubitemid 41457512)
44. Cinamon, G., M. A. Zachariah, O. M. Lam, F. W. Foss, Jr., and J. G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9: 54-62. (Pubitemid 350286204)
45. Lombard, C., M. Nagarkatti, and P. Nagarkatti. 2007. CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents. Clin. Immunol. 122: 259-270. (Pubitemid 46216921)
46. Do, Y., R. J. McKallip, M. Nagarkatti, and P. S. Nagarkatti. 2004. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J. Immunol. 173: 2373-2382. (Pubitemid 39063093)
47. Börner, C., M. Smida, V. Höllt, B. Schraven, and J. Kraus. 2009. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling. J. Biol. Chem. 284: 35450-35460.
48. Gunn, M. D., V. N. Ngo, K. M. Ansel, E. H. Ekland, J. G. Cyster, and L. T. Williams. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391: 799-803. (Pubitemid 28099679)
49. Karlsson, M. C., R. Guinamard, S. Bolland, M. Sankala, R. M. Steinman, and J. V. Ravetch. 2003. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198: 333-340. (Pubitemid 36987858)
50. Klein, T. W., C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman. 2003. The cannabinoid system and immune modulation. J. Leukoc. Biol. 74: 486-496. (Pubitemid 38040375)
51. Buckley, N. E. 2008. The peripheral cannabinoid receptor knockout mice: an update. Br. J. Pharmacol. 153: 309-318.
52. Derocq, J. M., M. Ségui, J. Marchand, G. Le Fur, and P. Casellas. 1995. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 369: 177-182.
53. Hsu, B. L., S. M. Harless, R. C. Lindsley, D. M. Hilbert, and M. P. Cancro. 2002. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168: 5993-5996. (Pubitemid 34620011)
54. Han, K. H., S. Lim, J. Ryu, C. W. Lee, Y. Kim, J. H. Kang, S. S. Kang, Y. K. Ahn, C. S. Park, and J. J. Kim. 2009. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc. Res. 84: 378-386.
55. Kurihara, R., Y. Tohyama, S. Matsusaka, H. Naruse, E. Kinoshita, T. Tsujioka, Y. Katsumata, and H. Yamamura. 2006. Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. J. Biol. Chem. 281: 12908-12918. (Pubitemid 43855384)
56. Chen, Y., M. Yu, A. Podd, R. Wen, M. Chrzanowska-Wodnicka, G. C. White, and D. Wang. 2008. A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development. Blood 111: 4627-4636.
57. Chu, H., A. Awasthi, G. C. White, II, M. Chrzanowska-Wodnicka, and S. Malarkannan. 2008. Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity. J. Immunol. 181: 3373-3383.
58. Croker, B. A., D. M. Tarlinton, L. A. Cluse, A. J. Tuxen, A. Light, F. C. Yang, D. A. Williams, and A. W. Roberts. 2002. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J. Immunol. 168: 3376-3386. (Pubitemid 34250401)
59. Walmsley, M. J., S. K. Ooi, L. F. Reynolds, S. H. Smith, S. Ruf, A. Mathiot, L. Vanes, D. A. Williams, M. P. Cancro, and V. L. Tybulewicz. 2003. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302: 459-462. (Pubitemid 37296274)
60. Lu, T. T., and J. G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297: 409-412. (Pubitemid 34790772)
61. Weill, J. C., S. Weller, and C. A. Reynaud. 2009. Human marginal zone B cells. Annu. Rev. Immunol. 27: 267-285.
62. Sipe, J. C., N. Arbour, A. Gerber, and E. Beutler. 2005. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J. Leukoc. Biol. 78: 231-238. (Pubitemid 40979962)
63. Xu, H., C. L. Cheng, M. Chen, A. Manivannan, L. Cabay, R. G. Pertwee, A. Coutts, and J. V. Forrester. 2007. Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. J. Leukoc. Biol. 82: 532-541. (Pubitemid 47367143)
64. Servettaz, A., N. Kavian, C. Nicco, V. Deveaux, C. Chéreau, A.Wang, A. Zimmer, S. Lotersztajn, B. Weill, and F. Batteux. 2010. Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis. Am. J. Pathol. 177: 187-196.
65. Tschöp, J., K. R. Kasten, R. Nogueiras, H. S. Goetzman, C. M. Cave, L. G. England, J. Dattilo, A. B. Lentsch, M. H. Tschöp, and C. C. Caldwell. 2009. The cannabinoid receptor 2 is critical for the host response to sepsis. J. Immunol. 183: 499-505.
66. Karsak, M., E. Gaffal, R. Date, L. Wang-Eckhardt, J. Rehnelt, S. Petrosino, K. Starowicz, R. Steuder, E. Schlicker, B. Cravatt, et al. 2007. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316: 1494-1497. (Pubitemid 46906619)
67. Muppidi, J. R., T. I. Arnon, Y. Bronevetsky, N. Veerapen, M. Tanaka, G. S. Besra, and J. G. Cyster. 2011. Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone. J. Exp. Med. 208: 1941-1948.